NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Merck’s temador/temazolmide will be considered a part of the DCVax-L treatment based on the trial, so for the treatment, their product would still be part of the process. As has been stated numerous times here, it’s possible that may change or evolve in the treatment of unmethylated GBM but for the most part, it’ll remain part of the treatment, thus remain consistent with the treatment model. That’s what I think with regards to GBM treatment anyway. :)